For example, Epidermal Growth Factor Receptor (EGFR) mutations are positively correlated with the expression of PD-L1 in lung cancer, and EGFR inhibitors can inhibit the transcription of PD-L1.13 This evidence concerns the gene EGFR and lung carcinoma.